A detailed history of Mutual Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mutual Advisors, LLC holds 3,420 shares of BIIB stock, worth $594,361. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,420
Previous 3,530 3.12%
Holding current value
$594,361
Previous $818,000 19.07%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$189.07 - $236.8 $20,797 - $26,048
-110 Reduced 3.12%
3,420 $662,000
Q2 2024

Jul 30, 2024

SELL
$190.52 - $236.72 $2,667 - $3,314
-14 Reduced 0.4%
3,530 $818,000
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $10,176 - $12,850
48 Added 1.37%
3,544 $764,000
Q4 2023

Jan 12, 2024

BUY
$222.59 - $267.94 $105,730 - $127,271
475 Added 15.72%
3,496 $904,000
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $164,138 - $185,256
-648 Reduced 17.66%
3,021 $776,000
Q2 2023

Jul 31, 2023

SELL
$275.25 - $318.06 $165,425 - $191,154
-601 Reduced 14.07%
3,669 $1.05 Million
Q1 2023

Apr 11, 2023

BUY
$256.56 - $292.34 $93,900 - $106,996
366 Added 9.38%
4,270 $1.19 Million
Q4 2022

Jan 12, 2023

SELL
$252.44 - $306.72 $36,603 - $44,474
-145 Reduced 3.58%
3,904 $0
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $788,299 - $1.09 Million
4,049 New
4,049 $1.08 Million
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $604,702 - $708,444
-2,489 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$236.26 - $355.63 $181,211 - $272,768
-767 Reduced 23.56%
2,489 $609,000
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $59,573 - $68,784
-225 Reduced 6.46%
3,256 $924,000
Q2 2020

Aug 05, 2020

BUY
$258.66 - $342.55 $900,395 - $1.19 Million
3,481 New
3,481 $931,000
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $209,775 - $328,113
-968 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$278.5 - $352.75 $64,612 - $81,838
232 Added 31.52%
968 $291,000
Q3 2018

Nov 15, 2018

BUY
$293.51 - $383.83 $216,023 - $282,498
736 New
736 $260,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.